Nadofaragene firadenovec
Drug Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Nadofaragene firadenovec |
| Trade Name | Adstiladrin |
| Synonyms | rAd-IFN|rAd-IFN-2b|Nadofaragene firadenove-vncg|SCH 721015|SCH721015|TR-002 |
| Drug Descriptions |
Adstiladrin (nadofaragene firadenovec) is a recombinant adenovirus that encodes IFN alpha 2B, which may have potential antitumor activity (PMID: 11922775). Adstiladrin (nadofaragene firadenovec) is FDA approved for use in patients with high-risk BCG unresponsive non-muscle invasive bladder cancer with carcinoma in situ (FDA.gov). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C71011 |
Filtering
- Case insensitive filtering will display rows if any text in any cell matches the filter term
- Use simple literal full or partial string matches
- Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
- Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
- Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")
Sorting
- Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
- Click on any column header arrows to sort by that column
- Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Celecoxib + Gemcitabine + Nadofaragene firadenovec | Celecoxib Gemcitabine Nadofaragene firadenovec | 0 | 1 |
| Docetaxel + Gemcitabine + Nadofaragene firadenovec | Docetaxel Gemcitabine Nadofaragene firadenovec | 0 | 1 |
| Nadofaragene firadenovec | Nadofaragene firadenovec | 0 | 6 |
| Nadofaragene firadenovec + Pembrolizumab | Nadofaragene firadenovec Pembrolizumab | 0 | 1 |
CKB BOOST